Echogo Core News Today

EchoGo Heart Failure, developed in partnership with the Mayo Clinic, helps physicians detect heart failure with preserved ejection fraction.

/PRNewswire/ -- A new study published today, Automated Echocardiographic Detection of Severe Coronary Artery Disease Using Artificial Intelligence, found that...

/PRNewswire/ -- A new study published today, Automated Echocardiographic Detection of Severe Coronary Artery Disease Using Artificial Intelligence, found that...

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, OTR/L, director of rehabilitation at a hard-hit nursing home in Michigan, received her first dose just before Christmas. nurse at...

Ultimately, because LYFS-CT may exclude minority patients who could benefit from LCS and underestimate the benefits of LCS, the authors of this AJR article suggested "augmenting LCS eligibility for minority patients using combinations of models"--specifically, the PLCOm2012 model in conjunction with LYFS-CT and USPSTF-2020. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

Share this article Share this article OXFORD, England, Jan. 6, 2021 /PRNewswire/ -- A world-first, AI powered, outcomes-driven, decision support tool – EchoGo Pro, has been cleared by the FDA and is now available to clinicians across the U.S. EchoGo Pro was trialed and validated in the UK and US, improving the diagnostic accuracy of clinicians for Coronary Artery Disease (CAD), the most common form of heart disease and leading cause of death in the U.S. Ultromics’ EchoGo Pro uses AI to ide...

FDA Clears Ultromics Echocardiography AI for Auto Identification of Coronary Artery Disease First-of-kind artificial intelligence solution in cardiac ultrasound will help clinicians diagnose disease Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the...